Skip to main content
. 2019 May 14;10(8):1391–1398. doi: 10.1039/c9md00140a

Table 1. MICs of MCAs against S. aureus and MRSA, μg mL–1 (μM). More details are provided in ref. 26.

Compound S. aureus MRSA
Cp*IrCl(L-phengly) >64 (>125) >64 (>125)
[Cp*IrCl(ethylenediamine)]Cl 35 (76.3) 33 (72.0)
[Cp*IrCl(N,N′-dimethylethylenediamine)]Cl 40 (82.2) 40 (82.2)
[Cp*IrCl(N-benzylethylenediamine)]Cl 7.5 (13.7) 7.5 (13.7)
[Cp*IrCl(cis-1,2-diaminocyclohexane)]Cl 5 (9.8) 7.5 (14.6)
[Cp*IrCl(trans-1,2-diaminocyclohexane)]Cl >64 (>125) >64 (>125)
[Cp*IrCl(ethambutol)]Cl 35 (58.1) 40 (66.4)
[Cp*IrCl2]2 >64 (>80.3) >64 (>80.3)
Ethylenediamine >64 (>1065) >64 (>1065)
cis-1,2-Diaminocyclohexane >64 (>560) >64 (>560)
trans-1,2-Diaminocyclohexane >64 (>560) >64 (>560)